Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1985-03-04
1989-05-23
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, 435 68, 435811, A61K 4502, C07K 1300, C12P 2100
Patent
active
048329592
ABSTRACT:
Partial sequences of human-.gamma.-interferon, comprising aminoacid sequences 5 to 127, 1 to 127 and 5 to 146, having biological activity. These partial sequences can be obtained by a genetic engineering process, for which purpose the appropriate DNA sequences are chemically synthesized. The DNA sequences are incorporated in hybrid plasmids, and the latter are introduced into host organisms and their expression is induced there. The biologically active polypeptides are suitable, as is human-.gamma.-interferon, for medicaments.
REFERENCES:
patent: 4457867 (1984-07-01), Ishida
patent: 4604284 (1986-08-01), Kung et al.
Devos et al., Nuclear Acid Research, vol. 10, pp. 2487-2501, 1982.
Gray et al., Nature, vol. 295, pp. 503-508, 1982.
Shepard et al., Nature, vol. 294, pp. 563-565, 1981.
Search Report issued in corresponding European Patent Application, EP 85 104 501.3.
Engels Joachim
Leineweber Michael
Uhlmann Eugen
Ulmer Wolfgang
Hazel Blondel
Hoechst Aktiengesellschaft
LandOfFree
Preparation of polypeptides having human .gamma.-interferon acti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of polypeptides having human .gamma.-interferon acti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of polypeptides having human .gamma.-interferon acti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1729925